<!DOCTYPE html>
<html class="no-js" lang="en" dir="ltr" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:schema="http://schema.org/" xmlns:fb="http://ogp.me/ns/fb#">

<head>
  <!-- Set gtm id codes for various environments. -->

	<!-- Google Tag Manager -->
	<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
	new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
	j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
	'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
	})(window,document,'script','dataLayer','GTM-W3ZV');</script>
	<!-- End Google Tag Manager -->
  <meta charset="utf-8">
    <title>Our Centre for Drug Development | Cancer Research UK</title>

  <script charset="UTF-8" src="//cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-domain-script="81232513-709c-4b95-8a41-a4b812c22fdc" async=""></script>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<link href="/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff" rel="preload" as="font" crossorigin="1">
<link href="/sites/all/themes/custom/cruk/fonts/Poppins-Regular.woff2" rel="preload" as="font" crossorigin="1">
<link rel="alternate" href="https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development" hreflang="en-gb">
<script>{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Organization",
            "additionalType": "NGO",
            "@id": "https://www.cancerresearchuk.org",
            "name": "Cancer Research UK",
            "address": {
                "@type": "PostalAddress",
                "streetAddress": "2 Redman Place",
                "addressRegion": "London",
                "postalCode": "E20 1JQ",
                "addressCountry": "UK"
            },
            "telephone": "03001234452",
            "url": "https://www.cancerresearchuk.org/",
            "sameAs": [
                "https://en.wikipedia.org/wiki/Cancer_Research_UK",
                "https://www.youtube.com/cancerresearchuk",
                "https://en-gb.facebook.com/cancerresearchuk",
                "https://twitter.com/CR_UK",
                "https://www.instagram.com/cr_uk",
                "https://www.linkedin.com/company/cancer-research-uk"
            ],
            "image": {
                "@type": "ImageObject",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            },
            "logo": {
                "@type": "ImageObject",
                "representativeOfPage": "True",
                "url": "https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/cruk-logo.svg"
            }
        }
    ]
}</script>
<meta name="description" content="At the CRUK CDD, we translate today's science into tomorrow's medicine. We are the partner of choice for early-phase cancer drug development.">
<link rel="canonical" href="https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development">
<link rel="shortlink" href="https://www.cancerresearchuk.org/node/185711">
<meta property="og:site_name" content="Cancer Research UK">
<meta property="og:type" content="article">
<meta property="og:title" content="Our Centre for Drug Development">
<meta property="og:url" content="https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development">
<meta property="og:description" content="At the CRUK CDD, we translate today's science into tomorrow's medicine. We are the partner of choice for early-phase cancer drug development.">
<meta property="og:updated_time" content="2025-02-27T14:11:15+00:00">
<meta property="og:image" content="https://www.cancerresearchuk.org/sites/default/files/drugcentre_hd_300dpi_cdd_title_small.png">
<meta name="twitter:card" content="summary">
<meta name="twitter:url" content="https://www.cancerresearchuk.org/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development">
<meta name="twitter:title" content="Our Centre for Drug Development">
<meta name="twitter:description" content="At the CRUK CDD, we translate today's science into tomorrow's medicine. We are the partner of choice for early-phase cancer drug development.">
<meta property="article:published_time" content="2017-01-24T17:49:28+00:00">
<meta property="article:modified_time" content="2025-02-27T14:11:15+00:00">

      <link rel="apple-touch-icon" sizes="57x57" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-57x57.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-60x60.png">
<link rel="apple-touch-icon" sizes="72x72" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-72x72.png">
<link rel="apple-touch-icon" sizes="76x76" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" sizes="114x114" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-114x114.png">
<link rel="apple-touch-icon" sizes="120x120" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" sizes="144x144" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-144x144.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-152x152.png">
<link rel="apple-touch-icon" sizes="60x60" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/apple-touch-icon-180x180.png">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="32x32">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-194x194.png" sizes="194x194">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-32x32.png" sizes="96x96">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/android-chrome-192x192.png" sizes="192x192">
<meta name="theme-color" content="#ffffff">
<link rel="icon" type="image/png" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon-16x16.png" sizes="16x16">
<link rel="manifest" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/manifest.json">
<link rel="shortcut icon" href="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicon.ico">
<meta name="msapplication-TileImage" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/mstile-144x144.png">
<meta name="msapplication-TileColor" content="#ec008c">
<meta name="msapplication-config" content="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/favicons/favicons/browserconfig.xml">
<meta name="apple-mobile-web-app-title" content="CRUK">
<meta name="application-name" content="CRUK">
  
  <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta http-equiv="cleartype" content="on">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <style>
@import url("https://www.cancerresearchuk.org/modules/system/system.base.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.menus.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.messages.css?");
@import url("https://www.cancerresearchuk.org/modules/system/system.theme.css?");
</style>
<style>@font-face{font-family:"MuseoSansRounded-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-500.ttf") format("truetype")}@font-face{font-family:"MuseoSansRounded-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSansRounded-700.ttf") format("truetype")}@font-face{font-family:"MuseoSans-500";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-500.ttf") format("truetype")}@font-face{font-family:"MuseoSans-700";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot");src:url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.eot?#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff2") format("woff2"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/museo/MuseoSans-700.ttf") format("truetype")}@font-face{font-family:"Progress";font-display:swap;src:url("/sites/all/themes/custom/cruk/fonts/progress/Progress-Regular.woff")}@font-face{font-family:'CRUKIcons';src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot");src:url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.eot#iefix") format("embedded-opentype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.woff") format("woff"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.ttf") format("truetype"),url("/sites/all/themes/custom/cruk/fonts/cruk-icons/CRUKIcons.svg#CRUKIcons") format("svg");font-weight:normal;font-style:normal}.cr-i{display:inline-block;font:normal normal normal 14px/1 CRUKIcons;font-size:inherit;text-rendering:auto;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;speak:none}.cr-i--chevron-down:before{content:"\e905"}body{font-family:"Arial",sans-serif;font-size:14px;padding:0}.container{max-width:960px}*,*:before,*:after{-moz-box-sizing:border-box;-webkit-box-sizing:border-box;box-sizing:border-box}.inner{width:auto;margin:0}@media screen and (min-width: 981px){.inner{width:940px;margin:0 auto}}@media screen and (max-width: 480px){.wrapper{overflow:visible}}@media screen and (min-width: 981px){.wrapper{overflow:hidden;padding-top:0}}/*! normalize.css v2.1.3 | MIT License | git.io/normalize */article,aside,details,figcaption,figure,footer,header,hgroup,main,nav,section,summary{display:block}audio,canvas,video{display:inline-block}audio:not([controls]){display:none;height:0}[hidden],template{display:none}html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}a{background:transparent}a:focus{outline:thin dotted}a:active,a:hover{outline:0}h1{font-size:2em;margin:0.67em 0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:bold}dfn{font-style:italic}hr{-moz-box-sizing:content-box;box-sizing:content-box;height:0}mark{background:#ff0;color:#000}code,kbd,pre,samp{font-family:monospace, serif;font-size:1em}pre{white-space:pre-wrap}q{quotes:"\201C" "\201D" "\2018" "\2019"}small{font-size:80%}sub,sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-0.5em}sub{bottom:-0.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:0}fieldset{border:1px solid #c0c0c0;margin:0 2px;padding:0.35em 0.625em 0.75em}legend{border:0;padding:0}button,input,select,textarea{font-family:inherit;font-size:100%;margin:0}button,input{line-height:normal}button,select{text-transform:none}button,html input[type="button"],input[type="reset"],input[type="submit"]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}input[type="checkbox"],input[type="radio"]{box-sizing:border-box;padding:0}input[type="search"]{-webkit-appearance:textfield;-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box}input[type="search"]::-webkit-search-cancel-button,input[type="search"]::-webkit-search-decoration{-webkit-appearance:none}button::-moz-focus-inner,input::-moz-focus-inner{border:0;padding:0}textarea{overflow:auto;vertical-align:top}table{border-collapse:collapse;border-spacing:0}.container{width:auto;margin-left:auto;margin-right:auto}html{line-height:1.5}body{background-color:#f5f5f5;color:#333}h1{font-size:28px;line-height:1em}@media screen and (max-width: 640px){h1{font-size:23.996px;line-height:1.08em}}h2{font-size:21px;line-height:1.1em}main>h1{clear:both;margin-top:0;padding:15px 0 20px 10px}h1,h2{margin:0 0 .5em;color:#333}h2 a:link{text-decoration:none}p{margin:0 0 1em}header{overflow:hidden}input,button{white-space:normal}a:link{color:#2E008B}.more{margin-bottom:0;list-style:none}.more a{background:transparent url("/sites/all/themes/custom/cruk/images/pink-arrow.png") no-repeat 0 center;color:#e40085;text-decoration:none;padding-left:15px;font-weight:bold}input[type="submit"]{padding:11px 20px;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.button{text-align:center;margin:.5em auto;display:inline-block}.secondary-button a {padding: 11px 10px;text-decoration: none !important;font-family: "MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size: 16px;line-height: 21px;text-align: center;color: #e40085;background-color: #ffffff;border: 1px solid #e40085;border-radius: 3px}.button a{padding:11px 20px;text-decoration:none !important;display:block;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif;font-size:16.002px;line-height:1.125em;text-align:center;color:#fff;background-color:#e40085;border:none;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px}.site-slogan{color:#2E008B}.lazyloader-icon{position:absolute;z-index:200}.lazyloader-icon{border:3px solid #E4E4E4;border-radius:50%;border-top:3px solid #00b6ed;width:20px;height:20px;-webkit-animation:spin 2s linear infinite;animation:spin 2s linear infinite;display:block;position:absolute;top:50%;left:50%;margin-left:-10px;margin-top:-10px}.siteinfo{background-color:#fff;display:flex;align-items:center;justify-content:space-between;padding-top:0}.siteinfo a{text-decoration:none}a.mhead-right{text-decoration:none}a.mhead-right:link,a.mhead-right:visited{padding:11px 20px;background-color:#e40085;-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;text-align:center;color:#fff;font-size:16.002px;line-height:1.125em;font-family:"MuseoSansRounded-700","MuseoSans-700","Arial","Helvetica",sans-serif}a.mhead-right:focus,a.mhead-right:hover,a.mhead-right:active{background-color:#F033A3}.site-slogan{font-size:1.7em;line-height:1.4em;font-family:"Progress","Arial","Helvetica",sans-serif;margin-bottom:0;color:#000}.site-slogan>a:hover,.site-slogan>a:visited{text-decoration:none;color:#2E008B}.page-node-64706 .siteinfo .mhead-right{display:none}#breadcrumb{background-color:#f5f5f5}#breadcrumb .breadcrumb{font-size:.833em;display:inline;color:#333}@media screen and (max-width: 480px){#breadcrumb{padding:9px 10px 0}}@media screen and (min-width: 481px) and (max-width: 640px){#breadcrumb{padding:9px 20px 0}}@media screen and (min-width: 641px) and (max-width: 800px){#breadcrumb{padding:9px 45px 0}}@media screen and (min-width: 801px) and (max-width: 980px){#breadcrumb{padding:11px 20px 0}}@media screen and (min-width: 981px){#breadcrumb{padding:13px 20px 0}}.in-maintenance .siteinfo{padding-bottom:10px}.in-maintenance #footer-txt{display:none}#dd-searchform{display:flex}#dd-searchform>input{box-sizing:border-box}#cruk-search{font-size:16px;padding:0 0 0 5px}#cruk-search .search{height:40px;width:145px;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border:2px solid #C8C8C8;border-right-width:0;border-top-right-radius:0;border-bottom-right-radius:0;padding:1px 0 0 1em}#cruk-search .search::placeholder{color:#C8C8C8}#cruk-search .searchsubmit{border:2px solid #C8C8C8;-moz-border-radius:4px;-webkit-border-radius:4px;border-radius:4px;border-bottom-left-radius:0;border-top-left-radius:0;border-left-width:0;background-color:#fff;color:#C8C8C8}#cruk-search .search:focus{border-color:#00B6ED;outline-width:0}#cruk-search .search:focus+.searchsubmit{border-color:#00B6ED;color:#2E008B}header{background-color:#fff}.header-region{border-top:1px solid #e3e3e3;border-bottom:1px solid #e3e3e3;background-color:#fafafa}.header-region nav{display:none}.megamenu{display:flex;justify-content:space-between;align-items:center;border:none;padding:0;margin:0;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;list-style:none}.megamenu p{margin:0}.megamenu .clear-fix{float:none;clear:both;margin:0;padding:0;height:0;font-size:0;line-height:0}.megamenu>li>div{display:none}.mm-item>p{display:flex;height:60px}.mm-item-link:link,.mm-item-link:visited{color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-weight:500;font-size:17px;text-decoration:none;padding:0 5px;line-height:20px;z-index:10;display:flex;align-items:center;border-left:1px solid transparent}.mm-item-link:link+.cr-i,.mm-item-link:visited+.cr-i{color:#A7A8AA;display:flex;align-items:center;border-right:1px solid transparent;padding-right:5px}.mm-item-link:last-child{border-right:1px solid transparent}.mm-item-link-hover:link,.mm-item-link-hover:visited{color:#e40085;padding-right:5px;border-color:#e3e3e3;z-index:1001}.mm-item-link-hover:link+.cr-i,.mm-item-link-hover:visited+.cr-i{color:#e40085;border-color:#e3e3e3}.mm-item.selected p>.mm-item-link.mm-item-link,.mm-item.selected p>.cr-i--chevron-down{color:#e40085}.mm-item-content{background-color:#fafafa;border:1px solid #e3e3e3;height:auto;margin-top:1px;position:absolute;z-index:101}.list-content,.list-content ul{padding:0;list-style:none}.toplevel{color:#2E008B;padding:12px 0 5px 20px;width:187px;float:left}.toplevel>p{font-size:14px;line-height:17px}.toplevel>p a{text-decoration:none;color:#2E008B}.toplevel>ul{height:auto;padding:10px 0 0}.toplevel li{margin-bottom:10px}.level3:link,.level3:visited{color:#333;text-decoration:none;font-size:14px;font-weight:normal;line-height:18px;padding-top:0}.level3:hover{color:#e40085}.cruk-logo img{width:100%;height:auto;display:block}#masthead_table{display:none !important}#mobile-rebrand-wrapper{display:block}@media screen and (min-width: 980px){#masthead_table{display:block !important}#mobile-rebrand-wrapper{margin:0 -16px;display:none}}.skip-link{width:100%}.skip-link .element-focusable:focus{position:absolute !important}#main-content:focus{outline:none !important}#mobile-navbar-container{background-color:#FAFAFA}#mobile-rebrand-wrapper #mobile-navbar-container>ul{margin-top:0;display:flex;justify-content:flex-start;height:50px;border-bottom:1px solid #e3e3e3}#mobile-rebrand-wrapper #mobile-navbar-container>ul li{display:flex;align-items:center}@media screen and (max-width: 800px){#top-page,#cruk-search,.site-slogan{display:none}.cruk-logo{padding-left:45px}.mhead-right{margin-right:45px}.siteinfo{padding-top:17px;padding-bottom:17px}}@media screen and (min-width: 481px) and (max-width: 800px){.site-slogan{display:none}}@media screen and (max-width: 480px){.cruk-logo{flex-basis:40%;padding-left:17px}.mhead-right{margin-right:15px}}@media screen and (min-width: 481px) and (max-width: 640px){.cruk-logo{padding-left:20px;width:140px}.mhead-right{margin-right:20px}}@media screen and (min-width: 800px) and (max-width: 980px){.cruk-logo{margin-left:20px}#cruk-nav{padding-left:20px}.mhead-right{margin-right:20px}#cruk-search{display:none}}@media screen and (min-width: 800px){.siteinfo{margin-top:30px;margin-bottom:17px}}.panel-related-row:before,.panel-related-row:after{content:" ";display:table}.panel-related-row:after{clear:both}.pane-promo,.feed-list,.pane-img-text,.pane-bundle-two-column-multi-alignment{background-color:#fff}.grey-panel{background-color:#e3e3e3}.blue-panel img,.white-panel img,.grey-panel img,.pane-show-hide img,.feed-list img,.pane-promo img,.pane-img-text img,.pane-bundle-two-column-multi-alignment img{width:100%;height:auto}.pane-bundle-donation-pane{display:none;background-repeat:no-repeat;background-size:cover;background-position:center}.pane-bundle-donation-pane.visible{display:block}.pane-bundle-donation-pane fieldset{padding:0;margin:0;border:0}.pane-bundle-donation-pane:after{display:none}.pane-bundle-donation-pane .pane-content{color:#fff;height:320px;margin-bottom:20px;text-align:center}.pane-bundle-donation-pane .pane-content:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}.pane-bundle-donation-pane .pane-content form>div{height:100%}.pane-bundle-donation-pane .pane-content h2{color:#fff;font-size:1.86em;line-height:1.1em;margin-bottom:.2em;margin-left:auto;margin-right:auto;max-width:260px}@media screen and (min-width: 800px){.pane-bundle-donation-pane .pane-content h2{line-height:1.4em;margin-bottom:.35em;max-width:600px}}.pane-bundle-donation-pane .pane-content .form-radios label{display:inline}.homepage .pane-bundle-donation-pane{background-repeat:no-repeat;border-radius:0;background-color:#2E008B}.homepage .pane-bundle-donation-pane .pane-content:before{display:none}.homepage .pane-bundle-donation-pane .pane-content form{height:100%;display:block;padding:1em;position:relative}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .pane-content form{float:right}}@media screen and (min-width: 801px){.homepage .pane-bundle-donation-pane .pane-content form{width:38%}}.homepage .pane-bundle-donation-pane .pane-content form>div{height:100%}.homepage .pane-bundle-donation-pane .pane-content form>div:before{content:"";display:inline-block;height:100%;vertical-align:middle;margin-right:-0.25em}.homepage .pane-bundle-donation-pane .form-steps{display:inline-block;vertical-align:bottom;margin-bottom:.5em}@media screen and (min-width: 641px){.homepage .pane-bundle-donation-pane .form-steps{vertical-align:middle}}.direct-donation-v2-pane.pane-bundle-donation-pane{display:block;background-position:30%}@media screen and (min-width: 800px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:left}}@media screen and (min-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane{background-position:15%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{height:100%;width:100%;padding:1em;display:table}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:63%}}.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{display:table-cell;padding-bottom:0;vertical-align:bottom}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .branding-content .branding-content-inner{padding:0 25% 0 0}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:22px;line-height:normal;text-shadow:0 0 20px rgba(0,0,0,0.75);width:100%;padding:0 0 .5em;margin-bottom:0;max-width:100%;text-align:center;letter-spacing:.03em}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:28px;text-align:left;padding:0 0 7% 5%}}.direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:none}.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{background-color:#fff;border-radius:0;z-index:1;display:block;margin-bottom:20px;padding:2em;position:relative;float:left;width:100%;box-sizing:border-box}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{float:none;padding:1em;position:absolute;top:3em;right:6em;max-width:calc(28% - 2em);margin-bottom:0}}@media screen and (max-width: 800px) and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{top:2em;right:2em;max-width:calc(33% - 2em)}}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .branding-content{padding-bottom:1em;width:67%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{padding:0 0 .5em;margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-heading{font-size:26px;line-height:40px;text-align:left;padding:0 0 0 20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{display:block;font-size:16px}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .donate-panel-subheading{font-size:18px;text-align:left;margin-left:20%}}.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{margin-bottom:0}@media screen and (min-width: 640px){.homepage .direct_donation_v2#cruk-donate-donation-pane-form .direct-donation-v2-form{right:2em;top:2em}}@media screen and (max-width: 640px){.direct-donation-v2-pane.pane-bundle-donation-pane .pane-content:before{display:none}}.direct_donation_v2#cruk-donate-donation-pane-form{padding:0;width:100%;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;display:block}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form{float:right}}.direct_donation_v2#cruk-donate-donation-pane-form>div:before{display:none}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type div{font-size:14px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{background-color:#fff;border:1px solid #2E008B;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label{padding:8px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type input[name="donation_type"]:checked+label{color:#fff;background-color:#2E008B}.direct_donation_v2#cruk-donate-donation-pane-form #edit-donation-type{display:flex;justify-content:space-between}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{display:flex;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;width:100%;color:#2E008B;background-color:#fff;margin-right:5%}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div:last-child,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div:last-child{margin-right:0px}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input{position:fixed;opacity:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{width:47%;display:inline-block;font-size:20px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{font-size:14px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div div{padding-top:30px;display:inline-block}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{background-color:#fff;border:2px solid #e3e3e3;color:#2E008B;display:block;font-weight:normal;padding:12px}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label{padding:4px 0px 4px 0px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div label:focus,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:hover,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div label:focus{background-color:#2E008B !important;color:#fff;cursor:pointer}.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div input:checked+label,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div input:checked+label{color:#fff;background-color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-single div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{border:none}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-single>div,.direct_donation_v2#cruk-donate-donation-pane-form #edit-monthly>div{padding:9px 0;font-size:inherit}}.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;margin-bottom:5%;color:#2E008B}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{font-size:16px}}@media screen and (max-width: 638px){.direct_donation_v2#cruk-donate-donation-pane-form .amount-separator{padding-top:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{position:absolute;font-size:20px;margin:13px 0 0 12px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .pound-symbol{font-size:18px;margin:8px 0 0 12px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{width:100%;padding:14px 10px 14px 35px;font-size:20px;color:#2E008B;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;border:2px solid #e3e3e3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other{padding:10px 10px 10px 35px;font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other:focus{border-color:#e40085;outline:0}.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:20px;color:#C8C9C7;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form #edit-amount-other::placeholder{font-size:15px}}.direct_donation_v2#cruk-donate-donation-pane-form .input-other-amnt-wrapper{float:none;display:block;position:relative}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{width:100%;height:50px;font-family:"MuseoSansRounded-500","MuseoSans-500","Arial","Helvetica",sans-serif;font-size:20px;color:#fff;background:#e40085;margin:10% 0 0 0;padding:0}.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn:hover{background:#F033A3}@media screen and (min-width: 640px){.direct_donation_v2#cruk-donate-donation-pane-form .submit-btn{font-size:16px;height:42px}}fieldset{-moz-border-radius:3px;-webkit-border-radius:3px;border-radius:3px;border:1px solid #e3e3e3;background-color:#fff;margin:0 0 20px 0;padding:15px 20px 20px;clear:both}
/*# sourceMappingURL=critical.css.map */
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.core.min.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/jquery.ui.theme.min.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/modules/aggregator/aggregator.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/css/grand_challenge_timeline.css?");
@import url("https://www.cancerresearchuk.org/modules/field/theme/field.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.css?");
@import url("https://www.cancerresearchuk.org/modules/node/node.css?");
@import url("https://www.cancerresearchuk.org/modules/search/search.css?");
@import url("https://www.cancerresearchuk.org/modules/user/user.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/css/extlink.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/views/css/views.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ckeditor/css/ckeditor.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/ctools/css/ctools.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/panels/css/panels.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/layouts/100_333_73_landing_wide_multi_panels/100_333_73_landing_wide_multi_panels.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/modules/contrib/node_embed/plugins/node_embed/node_embed.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/tabs_to_accordion.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/style.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/cruk.menus.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/mobile.menu.css?");
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/slick.css?");
</style>
<style media="print">
@import url("https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/css/print.css?");
</style>
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_31.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_131.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_156.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_196.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_201.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_206.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_211.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_226.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_241.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_251.css?" media="screen">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_261.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_276.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_281.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_291.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_296.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_306.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_361.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_371.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_376.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_426.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_441.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_466.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_471.css?");
</style>
<style media="screen">
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_516.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_561.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_576.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_581.css?">
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_610.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_616.css?");
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_617.css?");
</style>
<link rel="stylesheet" href="https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_619.css?">
<style>
@import url("https://www.cancerresearchuk.org/sites/default/files/css_injector/css_injector_620.css?");
</style>
  <script>
    window.CancerResearchUK = {};
  </script>
    <!--[if lt IE 9]>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/respond.min.js"></script>
  <script src="https://www.cancerresearchuk.org/sites/all/themes/contrib/mothership/mothership/js/html5.js"></script>
  <![endif]-->

  </head>

<body class="not-front no-sidebars page-node page-node- page-node-185711 node-type-landing-page">

<!-- The gtm id code variable ($gtm_code) is set in gtm-header.inc.php -->

  <!-- Google Tag Manager (noscript) -->
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W3ZV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
  <!-- End Google Tag Manager (noscript) -->

<div id="top-page">
  <div class="inner">
    <div class="skip-link"><a href="#main-content" class="element-invisible element-focusable">Skip to main content</a></div>
  </div>
</div>


<header role="banner">
  <div class="siteinfo inner">
          <div class="cruk-logo">
        <a href="/" title="Cancer Research UK Homepage" rel="home">
          <img src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk_integrated_campaign/logo.svg" width="222" height="86" alt="Cancer Research UK Homepage">
        </a>
      </div>
    
          <p class="site-slogan">Together we are beating cancer</p>
    
    
    <div id="cruk-search">
      <form action="https://find.cancerresearchuk.org/" id="dd-searchform">
        <input type="hidden" value="1" name="siteid">
        <input type="text" class="search" placeholder="Search" name="q" id="q">
        <button aria-label="Search" name="searchsubmit" id="searchsubmit" class="searchsubmit">
          <span class="cr-i cr-i--search"></span>
        </button>
      </form>
    </div>



    <a class="mhead-right" href="/get-involved/donate/">Donate</a>
  </div><!-- #siteinfo -->

  <div class="header-region">
    <div class="inner">
            <!-- start: ul megamenu -->
      <div>
    <div id="cruk-nav">
      <div id="masthead_table">
        <ul class="megamenu" id="drupal-mdd"><li class="mm-item"><p><a href="/about-cancer/" class="mm-item-link">About cancer</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-cancer-menu"><li class="toplevel"><p><a href="/about-cancer/type" class="level2">Cancer types</a></p><ul><li><a href="/about-cancer/breast-cancer" class="level3">Breast cancer</a></li><li><a href="/about-cancer/bowel-cancer" class="level3">Bowel cancer</a></li><li><a href="/about-cancer/lung-cancer" class="level3">Lung cancer</a></li><li><a href="/about-cancer/prostate-cancer" class="level3">Prostate cancer</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/cancer-in-general" class="level2">Cancers in general</a></p><ul><li><a href="/about-cancer/cancer-symptoms" class="level3">Symptoms</a></li><li><a href="/about-cancer/screening" class="level3">Screening</a></li><li><a href="/about-cancer/tests-and-scans" class="level3">Tests</a></li><li><a href="/about-cancer/treatment" class="level3">Treatment</a></li><li><a href="/about-cancer/find-a-clinical-trial" class="level3">Clinical trials</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/causes-of-cancer" class="level2">Causes of cancer</a></p><ul><li><a href="/about-cancer/causes-of-cancer/smoking-and-cancer" class="level3">Smoking</a></li><li><a href="/about-cancer/causes-of-cancer/alcohol-and-cancer" class="level3">Alcohol</a></li><li><a href="/about-cancer/causes-of-cancer/diet-and-cancer" class="level3">Diet</a></li><li><a href="/about-cancer/causes-of-cancer/bodyweight-and-cancer" class="level3">Obesity</a></li><li><a href="/about-cancer/causes-of-cancer/sun-uv-and-cancer" class="level3">Sun and UV</a></li></ul></li><li class="toplevel"><p><a href="/about-cancer/coping-with-cancer" class="level2">Coping with cancer</a></p><ul><li><a href="/about-cancer/coping-with-cancer/coping-physically/" class="level3">Managing symptoms and side effects</a></li><li><a href="/about-cancer/coping/mental-health-cancer" class="level3">Mental health and cancer</a></li><li><a href="/about-cancer/coping-with-cancer/coping-practically/" class="level3">Money and travel</a></li><li><a href="/about-cancer/coping-with-cancer/dying/" class="level3">Death and dying</a></li><li><a href="https://cancerchat.cancerresearchuk.org/" class="level3">Cancer Chat forum</a></li></ul></li><li class="toplevel"><p><a href="/health-professional" class="level2">Health Professionals</a></p><ul><li><a href="/health-professional/cancer-statistics" class="level3">Cancer Statistics</a></li><li><a href="/health-professional/screening" class="level3">Cancer Screening</a></li><li><a href="/health-professional/learning-and-support" class="level3">Learning and Support</a></li><li><a href="/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" class="level3">NICE suspected cancer referral guidelines</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved" class="mm-item-link">Get involved</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="get-involved-menu"><li class="toplevel"><p><a href="/get-involved/donate" class="level2">Donate</a></p><ul><li><a href="/get-involved/donate" class="level3">Make a donation</a></li><li><a href="/get-involved/leave-a-legacy-gift-in-your-will" class="level3">Leave a legacy gift</a></li><li><a href="/get-involved/donate/donate-in-memory" class="level3">Donate in memory</a></li><li><a href="/get-involved/donate/philanthropy" class="level3">Philanthropy</a></li><li><a href="/node/143661" class="level3">Weekly Lottery</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/find-an-event" class="level2">Find an event</a></p><ul><li><a href="https://raceforlife.cancerresearchuk.org/" class="level3">Race for Life</a></li><li><a href="/get-involved/find-an-event/charity-runs" class="level3">Charity runs</a></li><li><a href="/get-involved/find-an-event/charity-walks-treks-and-hikes" class="level3">Charity walks</a></li><li><a href="https://find.cancerresearchuk.org/events?size=n_20_n&amp;sort-field=startDate&amp;sort-direction=asc" class="level3">Search events</a></li><li><a href="http://relay.cancerresearchuk.org" class="level3">Relay For Life</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/volunteer" class="level2">Volunteer</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in our shops</a></li><li><a href="/get-involved/volunteer/help-at-an-event" class="level3">Help at an event</a></li><li><a href="/get-involved/volunteer/help-us-raise-money" class="level3">Help us raise money</a></li><li><a href="/how-to-cancer-campaign" class="level3">Campaign for us</a></li></ul></li><li class="toplevel"><p><a href="/get-involved/do-your-own-fundraising" class="level2">Do your own fundraising</a></p><ul><li><a href="/get-involved/do-your-own-fundraising/fundraising-ideas" class="level3">Fundraising ideas</a></li><li><a href="/get-involved/do-your-own-fundraising/get-fundraising-pack" class="level3">Get a fundraising pack</a></li><li><a href="/get-involved/do-your-own-fundraising/return-your-money" class="level3">Return fundraising money</a></li><li><a href="/get-involved/do-your-own-fundraising/target-your-fundraising" class="level3">Fundraise by cancer type</a></li><li><a href="/get-involved/do-your-own-fundraising/practical-fundraising-help/set-up-a-cancer-research-uk-giving-page" class="level3">Set up a Cancer Research UK Giving Page</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/get-involved/find-a-shop" class="level3">Find a shop or superstore</a></li><li><a href="/get-involved/become-a-partner" class="level3">Become a partner</a></li><li><a href="/get-involved/donate/kids-and-teens" class="level3">Cancer Research UK for Children &amp; Young People</a></li><li><a href="/get-involved/we-are" class="level3">Our We Are campaign</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/our-research" class="mm-item-link">Our research</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="our-research-menu"><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-type" class="level2">By cancer type</a></p><ul><li><a href="/node/198836" class="level3">Brain tumours</a></li><li><a href="/node/199166" class="level3">Skin cancer</a></li><li><a href="/node/196346/" class="level3">Breast cancer</a></li><li><a href="/our-research/our-research-by-cancer-type" class="level3">All cancer types</a></li></ul></li><li class="toplevel"><p><a href="/our-progress" class="level2">Our achievements timeline</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/our-research-by-cancer-subject" class="level2">By cancer topic</a></p><ul><li><a href="/node/206811" class="level3">New treatments</a></li><li><a href="/our-research/our-research-by-cancer-subject/our-research-on-cancer-biology" class="level3">Cancer biology</a></li><li><a href="/node/206651" class="level3">Cancer drugs</a></li><li><a href="/our-research/our-research-by-cancer-subject" class="level3">All cancer subjects</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-research-strategy" class="level2">Our research strategy</a></p><ul></ul></li><li class="toplevel"><p><a href="/our-research/involving-animals-in-research" class="level2">Involving animals in research</a></p><ul></ul></li></ul>
      </div>
    </li><li class="mm-item selected"><p><a href="/funding-for-researchers" class="mm-item-link">Funding for researchers</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="funding-for-researchers-menu"><li class="toplevel"><p><a href="/funding-for-researchers" class="level2">Research opportunities</a></p><ul><li><a href="/funding-for-researchers/research-opportunities-in-basic-science-and-discovery-research" class="level3">For discovery researchers</a></li><li><a href="/funding-for-researchers/clinical-research" class="level3">For clinical researchers</a></li><li><a href="/funding-for-researchers/research-opportunities-in-population-and-behavioural-research" class="level3">For population researchers</a></li><li><a href="/funding-for-researchers/drug-discovery-and-development" class="level3">In drug discovery &amp; development</a></li><li><a href="/funding-for-researchers/research-opportunities-in-early-detection-and-diagnosis" class="level3">In early detection &amp; diagnosis</a></li><li><a href="/funding-for-researchers/develop-your-research-career" class="level3">Develop your research career</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/our-funding-schemes?items_per_page=40" class="level2">Our funding schemes</a></p><ul><li><a href="/funding-for-researchers/our-funding-schemes/career-development-fellowship" class="level3">Career Development Fellowship</a></li><li><a href="/funding-for-researchers/our-funding-schemes/discovery-programme-awards" class="level3">Discovery Programme Awards</a></li><li><a href="/funding-for-researchers/our-funding-schemes/clinical-research-funding-scheme" class="level3">Clinical Research Funding Scheme</a></li><li><a href="/funding-for-researchers/our-funding-schemes/biology-to-prevention-award" class="level3">Biology to Prevention Award</a></li><li><a href="/funding-for-researchers/our-funding-schemes" class="level3">View all schemes and deadlines</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/applying-for-funding" class="level2">Applying for funding</a></p><ul><li><a href="/funding-for-researchers/applying-for-funding/start-your-funding-application-online" class="level3">Start your application online</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application" class="level3">How to make a successful application</a></li><li><a href="/funding-for-researchers/applying-for-funding/funding-committees" class="level3">Funding committees</a></li><li><a href="/funding-for-researchers/applying-for-funding/how-to-make-a-successful-application/successful-applicant-case-studies" class="level3">Successful applicant case studies</a></li></ul></li><li class="toplevel"><p><a href="/funding-for-researchers/how-we-deliver-research" class="level2">How we deliver research</a></p><ul><li><a href="/funding-for-researchers/our-research-strategy" class="level3">Our research strategy</a></li><li><a href="/funding-for-researchers/our-research-infrastructure" class="level3">Our research infrastructure</a></li><li><a href="/funding-for-researchers/research-events-and-conferences" class="level3">Events and conferences</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/our-research-partnerships" class="level3">Our research partnerships</a></li><li><a href="/funding-for-researchers/facts-and-figures-about-our-research-funding" class="level3">Facts &amp; figures about our funding</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/funding-for-researchers/patient-involvement-toolkit-for-researchers" class="level3">Patient involvement toolkit for researchers</a></li><li><a href="/funding-for-researchers/how-we-deliver-research/recently-funded-awards" class="level3">Recently funded awards</a></li><li><a href="/funding-for-researchers/manage-your-research-grant" class="level3">Manage your research grant</a></li><li><a href="/home/funding-for-researchers/manage-your-research-grant/tell-us-about-new-publications" class="level3">Notify us of new publications</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/get-involved/ways-to-shop" class="mm-item-link">Shop</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="shop-menu"><li class="toplevel"><p><a href="/get-involved/find-a-shop" class="level2">Find a shop</a></p><ul><li><a href="/get-involved/volunteer/volunteer-in-our-shops" class="level3">Volunteer in a shop</a></li><li><a href="/get-involved/donate/donate-goods" class="level3">Donate goods to a shop</a></li><li><a href="/get-involved/ways-to-shop/superstores" class="level3">Our superstores</a></li></ul></li><li class="toplevel"><p><a href="https://shop.cancerresearchuk.org/" class="level2">Shop online</a></p><ul><li><a href="https://shop.cancerresearchuk.org/pages/race-for-life" class="level3">Race for Life</a></li><li><a href="https://shop.cancerresearchuk.org/products/wedding-favours" class="level3">Wedding favours</a></li><li><a href="https://shop.cancerresearchuk.org/cancer-care" class="level3">Cancer Care</a></li><li><a href="https://flowershop.cancerresearchuk.org/" class="level3">Flower Shop</a></li></ul></li><li class="toplevel"><p><a href="https://www.ebay.co.uk/str/ukcancerresearch" class="level2">Our eBay store</a></p><ul><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Dresses/_i.html?_storecat=13763243016" class="level3">Dresses</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Shoes-and-Boots/_i.html?_storecat=13763242016" class="level3">Shoes and boots</a></li><li><a href="https://www.ebay.co.uk/str/ukcancerresearch/Bags-Purses/_i.html?_storecat=13869673016" class="level3">Bags and purses</a></li></ul></li></ul>
      </div>
    </li><li class="mm-item"><p><a href="/about-us/" class="mm-item-link">About us</a><span class="cr-i cr-i--chevron-down"></span></p>
      <div style="width: 940px">
          <ul class="list-content" id="about-us-menu"><li class="toplevel"><p><a href="/about-us" class="level2">What we do</a></p><ul><li><a href="/our-research" class="level3">We beat cancer</a></li><li><a href="/get-involved/how-your-support-helps" class="level3">We fundraise</a></li><li><a href="/about-us/we-develop-policy" class="level3">We develop policy</a></li><li><a href="/global-role" class="level3">Our global role</a></li></ul></li><li class="toplevel"><p><a href="/about-us/our-organisation" class="level2">Our organisation</a></p><ul><li><a href="/about-us/our-organisation/beating-cancer-sooner-our-strategy" class="level3">Our strategy</a></li><li><a href="/about-us/how-we-are-run/our-trustees" class="level3">Our Trustees</a></li><li><a href="/about-us/how-we-are-run/chief-executive-and-executive-board" class="level3">CEO and Executive Board</a></li><li><a href="/about-us/our-organisation/how-we-spend-your-money" class="level3">How we spend your money</a></li></ul></li><li class="toplevel"><p><a href="/about-us/careers" class="level2">Careers</a></p><ul><li><a href="/about-us/careers/early-in-career-opportunities" class="level3">Early careers</a></li><li><a href="/about-us/careers/teams" class="level3">Our teams</a></li><li><a href="/about-us/careers/benefits" class="level3">Benefits</a></li></ul></li><li class="toplevel"><p><a href="https://news.cancerresearchuk.org/" class="level2">Cancer news</a></p><ul><li><a href="https://news.cancerresearchuk.org/" class="level3">Cancer News</a></li><li><a href="https://news.cancerresearchuk.org/for-researchers/" class="level3">For Researchers</a></li><li><a href="https://news.cancerresearchuk.org/for-supporters/" class="level3">For Supporters</a></li></ul></li><li class="toplevel"><p>More...</p><ul><li><a href="/about-us/contact-us" class="level3">Contact us</a></li><li><a href="/about-us/press-office" class="level3">Press office</a></li><li><a href="https://publications.cancerresearchuk.org" class="level3">Publications</a></li><li><a href="/about-us/contact-us/opt-in-form" class="level3">Update your contact preferences</a></li></ul></li></ul>
      </div>
    </li></ul>
      </div>
    </div>
  </div>
      <noscript>
        <ul class="megamenu js-off">
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-cancer">ABOUT CANCER</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/get-involved">GET INVOLVED</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/cancer-info">NEWS &amp; RESOURCES</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/science">FUNDING &amp; RESEARCH</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- start: top li -->
          <li class="mm-item"><p><a class="mm-item-link" href="/about-us">ABOUT US</a></p></li>
          <!-- end: top li -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
          <!-- ignore empty title -->
        </ul>
      </noscript>
      <!-- end: ul megamenu -->
    </div>
  </div><!-- .header-region -->
  <div id="breadcrumb">
    <div class="inner">
      <p class="element-invisible">You are here</p><div class="breadcrumb"><a href="/">Home</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt=""><a href="/funding-for-researchers">Funding for researchers</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt=""><a href="/funding-for-researchers/our-research-infrastructure" class="menu-node-unpublished menu-node-unpublished">Our research infrastructure</a><img src="/sites/all/themes/custom/cruk/images/breadcrumb-arrow.png" alt="">Our Centre for Drug Development</div>    </div>
  </div>
</header>


<div class="page">
  <div class="wrapper no-gutter container">
    <main role="main" id="main-content" tabindex="-1">
      <!-- start of main content -->
                    <h1>Our Centre for Drug Development</h1>
                  
      
      
            
    <div class="wide_100_73_333_multi">

   <div id="panel-row-0" class="panel-row top-section no-gutter col-md-12 col-sm-12 col-xs-12">
        
           </div>

                      <div id="panel-3" class="col-md-12 col-sm-12 col-xs-12">
                   <div class="panel-content">
                        
<div class="panel-pane pane-menu-tree pane-menu-centre-for-drug-development pane-menu-menu-horizontal-overview">
  
      <h2 class="pane-title">
  Centre for Drug Development</h2>



<div class="pane-content">
  <ul class="menu"><li class="first leaf active-trail active menu-mlid-538196 level-1"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development" title="" class="menu-node-unpublished active-trail active">Home</a></li>
<li class="leaf menu-mlid-538211 level-1"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-strategy-and-portfolio" title="" class="menu-node-unpublished">Strategy &amp; portfolio</a></li>
<li class="leaf menu-mlid-538201 level-1"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-our-capabilities-and-infrastructure" title="" class="menu-node-unpublished menu-node-unpublished menu-node-unpublished">Leadership &amp; capabilities</a></li>
<li class="leaf menu-mlid-538206 level-1"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-partnership-opportunities" title="" class="menu-node-unpublished">Partnership opportunities</a></li>
<li class="last leaf menu-mlid-538216 level-1"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/patient-involvement" title="" class="menu-node-unpublished">Patient Involvement</a></li>
</ul></div>


</div>
<div class="panel-separator"></div><div class="panel-pane pane-fieldable-panels-pane pane-current-28116 pane-promolh white-panel">
  
      
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_no_style/public/drugcentre_hd_300dpi_cdd_title_small.png?itok=CCz4xGBJ" alt="CRUK Centre for Drug Development" title="CRUK Centre for Drug Development"></div>
      
        </div>


<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><h1>We translate today's science into tomorrow's medicine</h1>
<div class="footnote">Â </div>
<p><span class="large-font">At the CRUK Centre for Drug Development (CDD) our goal is to bring much needed new treatments to people with cancer</span></p>
<p>We are the partner of choice for early phase cancer drug development. The academic, pharmaceutical and biotechnology sectors across the globe trust us to realise the full potential of their research.</p>
<p><span class="button"><a href="mailto:drugdev@cancer.org.uk">Get in touch</a></span></p>
</div>
        </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1 white-panel">
  
        <h2 class="pane-title">We have a proven track record</h2>
    
  
  <div class="pane-content">
    <style>
.research-brand-bg-panel {
    position: relative;
    padding: 20px;
    margin-bottom: 15px;
    overflow: hidden;
    z-index: 2;
}
.research-brand-bg-panel h1 { color: #2e008b; margin-top: 50px; margin-bottom: 20px; font-size: 600%; }
.research-brand-bg-panel h3 { color: #2e008b; font-size: 120%;  }
.research-brand-bg { 
    position: absolute; 
    left: 0; 
    top: 0; 
    width: 100%;
    z-index: -1; 
}
</style>
<p>We have 30 years experience partnering with industry and academia to turn promising research ideas into novel therapies, including antibodies, imaging agents, cell therapies, vaccines and targeted small molecules. Our portfolio rivals that of a medium-sized pharmaceutical company in size, but in form reflects our unique strategy as a charity-funded organisation.</p>

<div class="col-md-4 col-sm-4 col-xs-12 research-brand-bg-panel" style="text-align: center; height: 250px;">
<img src="https://www.cancerresearchuk.org/sites/default/files/small_-_png-molecule_blue_rgb_screen.png" class="research-brand-bg" style="opacity: 0.12; width: 80%; left: 10%;">
<h1>~20</h1>
<h3>AGENTS UNDER ACTIVE DEVELOPMENT</h3>
</div>

<div class="col-md-4 col-sm-4 col-xs-12 research-brand-bg-panel" style="text-align: center; height: 250px;">
<img src="https://www.cancerresearchuk.org/sites/default/files/small_-_jpg-partnership_blue_rgb_screen.jpg" class="research-brand-bg" style="opacity: 0.12; width: 80%; top: 10%; left: 10%;">
<h1>&gt;25</h1>
<h3>YEARS OF EXPERIENCE</h3>
</div>

<div class="col-md-4 col-sm-4 col-xs-12 research-brand-bg-panel" style="text-align: center; height: 250px;">
<img src="https://www.cancerresearchuk.org/sites/default/files/small_-_png-funding_period_blue_rgb_screen.png" class="research-brand-bg" style="opacity: 0.12; width: 70%; left: 15%;">
<h1>6</h1>
<h3>AGENTS HAVE BEEN REGISTERED AS MEDICINES</h3>
</div>

<div class="button"><p><a href="/funding-for-researchers/our-centre-for-drug-development/centre-for-drug-development-strategy-and-portfolio">Explore our portfolio and pipeline</a></p></div>  </div>

  
  </div>
                   </div>
              </div>
        

   <div id="panel-row-1" class="panel-row panel-related-row">
                      <div id="panel-4" class="col-md-6 col-sm-6 col-xs-12">
                <div class="panel-content">
                    
<div class="panel-pane pane-fieldable-panels-pane pane-current-27611 pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  <a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development">Our strategic priorities</a></h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_no_style/public/452_1.jpg?itok=C1RCVlEc" alt=""></div>
      
        </div>


<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><p>As the world's only charity-funded drug development facility, our pioneering research is driven purely by the goalÂ to see scientific breakthroughs bring benefits to patients sooner. Our priorities include:</p>
<ul>
<li>
	First in class therapies
	</li>
<li>
	<span>First in human clinical trials</span>
	</li>
</ul>
<p>Â </p>
<p>Â </p>
<p>Â </p>
</div>
        </div>


<div class="field field-type-link-field">
  
  
                <div class="field-item"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-strategy-and-portfolio" class="more">Discover more</a></div>
        </div>
</div>
</div>


</div>
                </div>
              </div>
        
                      <div id="panel-5" class="col-md-6 col-sm-6 col-xs-12">
                <div class="panel-content">
                    <div class="panel-pane pane-fieldable-panels-pane pane-current-27606 pane-promo white-panel">
  
        <h2 class="pane-title"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-our-capabilities-and-infrastructure">Our capabilities and infrastructure</a></h2>
    
  
  <div class="pane-content">
    <div class="fieldable-panels-pane">
    
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_no_style/public/small_-_png-13054_2.png?itok=-8U-1goi" alt=""></div>
      
        </div>


<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><p dir="ltr">We have the capabilities and infrastructure needed to demonstrate clinical potential.</p>
<p dir="ltr">With a team of over 100 drug development scientists and operational staff, our expertise spans preclinical and medical sciences, regulatory affairs, quality assurance, project management, legal, drug safety, clinical operations and data management.</p>
<p>We have a dedicated manufacturing facility which is licensed to produce small molecule drugs we use in our clinical trials, something unique in the non-commercial sector in Europe.</p>
</div>
        </div>


<div class="field field-type-link-field">
  
  
                <div class="field-item"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-our-capabilities-and-infrastructure" class="more">Discover more</a></div>
        </div>
</div>
  </div>

  
  </div>
                </div>
              </div>
            </div>

        
    <div id="panel-row-2" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-3" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-4" class="panel-row panel-related-row">
        
        
            </div>

    <div id="panel-row-5" class="panel-row panel-related-row">
        
        
            </div>

                     <div id="panel-19" class="panel-box panel-related-box col-md-12 col-sm-12 col-xs-12">
                 
<div class="panel-pane pane-fieldable-panels-pane pane-uuid-e80ad972-8d8f-41b5-8c8c-d908ad4303b9 pane-bundle-fieldable-panels-pane pane-promolh">
  
    


<div class="pane-content">
  <div class="fieldable-panels-pane">
    
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_no_style/public/small_-_png-molecule_blue_rgb_screen.png?itok=dmaXocTn" alt=""></div>
      
        </div>


<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><p><span class="large-font"><span class="quote-blue">Partnering with Cancer Research UK gives us a unique opportunity to make a real difference. We look forward to developing this partnership further with our shared competence, funding and core vision of improving the lives of those affected by cancer.</span></span></p>
<p align="right">Ingrid Stenstadvold Ross, General Secretary of the Norwegian Cancer Society</p>
</div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-28076 pane-bundle-fieldable-panels-pane pane-promo">
  
      <h2 class="pane-title">
  <a href="/funding-for-researchers/our-centre-for-drug-development/centre-for-drug-development-partnership-opportunities">We deliver progress through partnership</a></h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><p>Working in partnership is key to achieving our ambitions andÂ we have a number of flexible business models that allow us to collaborate effectively with you.</p>
<p>Our partnership models include:</p>
<ul>
<li>Clinical Development Partnerships, working with industry to bring new life to the most scientifically promising agents</li>
<li>Academic Sponsorship, offering full development of promising agents which come from academic research</li>
</ul>
<p>We are always looking to expand our portfolio of innovative, patient-focussed projects.</p>
<div class="more"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-partnership-opportunities">Find out more about how we can work together</a></div>
</div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div>
<div class="panel-pane pane-fieldable-panels-pane pane-current-27626 pane-bundle-fieldable-panels-pane pane-img-text">
  
      <h2 class="pane-title">
  <a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-our-capabilities-and-infrastructure">Our leadership team</a></h2>



<div class="pane-content">
  <div class="fieldable-panels-pane">
    
<!-- field-image.tpl.php -->
<div class="field field-type-image">
  
  
                <div class="field-item"><img typeof="foaf:Image" src="https://www.cancerresearchuk.org/sites/default/files/styles/cruk_no_style/public/cdd_lt_may_2024small.jpg?itok=NaTcR1Cm" alt="CDD LT May2024"></div>
      
        </div>


<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><p dir="ltr">Our leadership team of outstanding drug development professionals areÂ responsible for our day-to-day business operations and our strategic development.</p>
<p>The CDD has a team of over 100 scientists and operational staff, the majority of which are based at CRUK's head office in London. We have similar functional teams to pharmaceutical and biotechnology companies, to take promising discoveries from exploratory and preclinical phases through to sponsorship and into clinical trials.</p>
</div>
        </div>


<div class="field field-type-link-field">
  
  
                <div class="field-item"><a href="/funding-for-researchers/our-research-infrastructure/our-centre-for-drug-development/centre-for-drug-development-our-capabilities-and-infrastructure" class="more">Meet the team</a></div>
        </div>
</div>
</div>


</div>
<div class="panel-separator"></div><div class="panel-pane pane-fieldable-panels-pane pane-current-27616 white-panel">
  
      
  
  <div class="pane-content">
    <h2 class="content-panels-pane-header">News and features</h2><div class="content-panels-pane-intro-copy"><p>Keep up to date with the latest news and developments from our Centre for Drug Development.</p>
</div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/cruk_cdd_cmyk_2023_4.jpg" alt="CDD logo"></div><div class="content-panels-pane-body-copy"><h3>International partnerships are needed to develop new cancer treatments</h3>
<p>On International Clinical Trials Day <a href="https://www.linkedin.com/posts/larserwig_cancerresearch-internationalclinicaltrialsday-activity-7330606195642130435-Ibar/?utm_source">Lars Erwig</a>, Director of our Centre for Drug Development, talks to Drug Discovery World about developing treatments for rare cancers and the need for international collaboration with non-profits to fund more clinical trials while also facilitating patient recruitment. Our partnerships with the Norwegian Cancer Society (<a data-test-app-aware-link="" href="https://www.linkedin.com/company/kreftforeningen-norwegian-cancer-society/" tabindex="0" target="_self">Kreftforeningen</a>) and the Dutch Cancer Society (<a data-test-app-aware-link="" href="https://www.linkedin.com/company/kwf-kankerbestrijding/" tabindex="0" target="_self">KWF Kankerbestrijding</a>) do just that, recently treating our first patients outside the UK.</p>
<div class="more"><a href="https://www.ddw-online.com/we-need-international-partnerships-to-get-new-cancer-treatments-into-the-clinic-35031-202505/">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/1744794686047.png" alt="pat and lars"></div><div class="content-panels-pane-body-copy"><h3>Interview with Pat LoRusso AACR President 2025</h3>
<p><a href="https://www.linkedin.com/in/patricia-lorusso-b000729b/" id="ember158">Patricia LoRusso</a>,Â Chair of our New Agents Committee, in conversation with <a href="https://www.linkedin.com/posts/larserwig_patricia-lorusso-in-conversation-with-activity-7318568093260152833-bgqq?utm_source=" id="ember159">Lars Erwig</a>, Director of our Centre for Drug Development. She talks about her journey in cancer drug development, the mentors who shaped her career and how she became AACR President for 2025.Â Read the article to discover Patâs inspiring career and what to watch out for at this yearâs AACR Annual Meeting.</p>
<div class="more"><a href="https://news.cancerresearchuk.org/2025/04/15/from-inner-city-detroit-to-aacr-president/" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/nature.jpg" alt="nature"></div><div class="content-panels-pane-body-copy"><h3>New class of antibody shows promise for cancer patients</h3>
<p>MOv18 IgE is a novel class of antibody developed by researchers at <a href="https://www.kcl.ac.uk/news/trial-shows-promise-for-new-antibody-cancer-treatment">King's College London</a>Â that targetsÂ the folate receptor alpha antigen. Our Centre for Drug Development funded and supported the preclinical development of MOv18 IgE, then funded, sponsored and conducted <a href="https://clinicaltrials.gov/study/NCT02546921">the first in class Phase I clinical trial</a>Â led by Professor James Spicer at Guy's and St Thomas' Clinical Research Facility. A new paper sheds light on how treatment with MOv18 reactivates patients immune cells to fight ovarian cancer.<span><span><span>Â </span></span></span>Read more about it in Nature Communications.</p>
<div class="more"><a href="https://www.nature.com/articles/s41467-025-57870-y" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/sky_news_determine_pt.jpg" alt="sky news determine"></div><div class="content-panels-pane-body-copy"><h3>Patient finds hope with CDD's DETERMINE trial</h3>
<p>After her cancer treatment stopped working, Pamela Garner-JonesÂ matched to a treatment on our <a href="/about-cancer/find-a-clinical-trial/a-trial-of-targeted-treatment-for-rare-cancers-that-have-spread-determine">DETERMINE</a> trial via the TARGET National study, a molecular profiling programme that identifies mutations in certain genes. The results have been life-changing, with Pamela's tumours shrinking by two-thirds and her symptoms improving. Studies and trials like DETERMINE and TARGET National are paving the way for personalised cancer treatments, which can improve outcomes and cause fewer side effects, offering new hope and quality of life to patients.</p>
<p class="more">Â </p>
<div class="more"><a href="https://bit.ly/3Qx8crn" target="_blank">Watch Pamela's story here</a></div>
<div class="more"><a href="http://www.cruk.org/determine" target="_blank">Discover more about DETERMINE</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/www.pharmiweb_2.jpg" alt="cytovation logo"></div><div class="content-panels-pane-body-copy"><h3>CDD, the Norwegian Cancer Society and Cytovation collaborate to advance rare cancer treatment</h3>
<p>Cancer Research UK,Â <a href="https://www.cytovation.com/">Cytovation</a>Â and the <a href="https://kreftforeningen.no/en/">Norwegian Cancer Society</a>Â (NCS) signed an agreement to take Cytovation's lead asset, into a multi-national clinical trial. CY101 is a bifunctional peptideÂ thatÂ targets and destroys cancer cells triggering an immune response while also inhibiting Wnt/beta-catenin, a key driver of immunotherapy resistance. The trial will treat people with adrenocortical cancer (ACC), a rare and aggressive cancer with limited treatment options and an urgent need for new therapies. Two people with ACC showed a clear clinical benefit in a previous trial of CY101. The trial will be developed, sponsored and managed by our Centre for Drug Development withÂ NCS providing co-funding to support the trial.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-cytovation-and-norwegian-cancer-society-collaborate" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/20f1_kisoji_20biotechnology_20inc_5b3575f1_0.png" alt="kisoji logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and KisoJi partner to advance first naked TROP2 antibody into the clinic</h3>
<p>Cancer Research UK andÂ <a href="https://www.kisojibiotech.com/en/">KisoJi Biotechnology</a>Â signed a landmark agreement to bring Kisoji's lead asset into a first in human clinical trial. KJ103 is a naked anti-TROP2 antibody created by Kisoji using their proprietary technology.Â The trial will treat people with TROP2 expressing tumours which include colorectal, head &amp; neck, ovarian, breast and bladder cancers. The trial will be developed, sponsored and managed by our Centre for Drug Development and led by Professor Christian Ottensmeier atÂ <a href="https://www.clatterbridgecc.nhs.uk/">The Clatterbridge Cancer Centre</a>Â in Liverpool.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-and-kisoji-partner-for-first-naked-antibody" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/christie_nurse_n_0.jpg" alt="christie nurse"></div><div class="content-panels-pane-body-copy"><h3>First patient dosed in CDD first in human trial of new immunotherapy</h3>
<p>The first patient has been treated inÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-a-drug-called-ucb4594-for-cancer-that-has-spread">our trial of HLA-G antibody UCB4594</a>, the second trial in our collaboration withÂ <a href="https://www.ucb.com/">UCB</a>. UCB4594 will be given to people with advanced cancer to prime their immune system to attack their cancer. Our Centre for Drug Development is sponsoring and managing the trial, which is led by Professor Fiona Thistlethwaite at the <a href="https://www.christie.nhs.uk/">Christie NHS Foundation Trust</a>Â in Manchester with other UK sites to follow.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-announces-dosing-first-patient-UCB4594-trial" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/novalgen-2jpg.jpg" alt="novalgen logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and NovalGen collaborate to advance T cell engager into the clinic</h3>
<p>Cancer Research UK and <a href="https://www.novalgen.com/">NovalGen</a>, a pioneering clinical stage immunology company, announce a collaboration to bring NovalGen's next generation T cell engager into two first in human clinical trials. NVG222 is a bispecific T cell engager, targeting ROR1 and CD3, with an in-built autoregulation technology to mitigate toxicity and improve effectiveness for treating people with blood cancer or solid tumours. The trials will be developed, sponsored and managed by our Centre for Drug Development and led by Dr William Townsend at <a href="https://www.uclh.nhs.uk/">University College London Hospitals</a>Â and Professor James Spicer at <a href="https://www.guysandstthomas.nhs.uk/">Guy's and St Thomas'</a>.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-events/cancer-research-uk-and-novalgen-collaborate-advance-t-cell-engager-clinic" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/rmh_patient_847x492.jpg" alt="RMH patient"></div><div class="content-panels-pane-body-copy"><h3>Results of our trial ofÂ Bicycle Therapeutics' first in class BicycleÂ® Toxin Conjugate</h3>
<p>See the results of our clinical trial of BT1718 in people with squamous non-small cell lung cancerÂ and other MT1-MMP expressing cancers. The trial was led byÂ <a href="https://www.icr.ac.uk/our-research/researchers-and-groups/professor-udai-banerji">Professor Udai Banerji at the Institute of Cancer Research</a>.</p>
<div class="more"><a href="https://www.isrctn.com/ISRCTN11160449" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/esmo-congress-2024-1000x250_i1920.jpg" alt="esmo24"></div><div class="content-panels-pane-body-copy"><h3>CDD's trial of Nxera's cancer immunotherapy at ESMO</h3>
<p><a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-htl0039732-and-other-cancer-drugs-for-solid-tumours-that-have-spread">Our trial </a>of <a href="https://www.nxera.life/">Nxera's</a>Â novel EP4 antagonist HTL0039732 led by Dr Bristi Basu at theÂ <a href="https://www.ecmcnetwork.org.uk/cambridge">Cambridge Experimental Cancer Medicine Centre</a>Â was presented at the European Society for Medical Oncology Congress in Barcelona (ESMO 2024).Â  Read the poster <a href="/Posters%20-%20ESMO%20Congress%202024%20%28ctimeetingtech.com%29">here</a>.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-and-events/our-news/cancer-research-uk-present-phase-1/2a-clinical-trial-cancer-immunotherapy" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/cruk_cdd_cmyk_2023_1.jpg" alt="CDD logo"></div><div class="content-panels-pane-body-copy"><h3>Making a real difference in cancer</h3>
<p>Lars Erwig, our Director of Drug Development, talks to The Medicine Maker about about developing treatments for rare cancers and the need for pharma companies to increase collaboration with non-profits to deliver the best outcomes for patients.</p>
<div class="more"><a href="//themedicinemaker.com/discovery-development/lets-make-a-real-difference-in-cancer">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/webimage-923f92a4-3ec4-4dca-be46a0bd4bef6d57_1.png" alt="iv treatment"></div><div class="content-panels-pane-body-copy"><h3>First patient dosed in CDD Phase II trial of new pancreatic drug ginisortamab</h3>
<p>The first patient has been treated inÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-ginisortamab-for-pancreatic-cancer-that-has-spread">our trial of UCB's antibody ginisortamab</a>, part of our collaboration with <a href="https://www.ucb.com/">UCB</a>. Ginisortamab will be given with standard chemotherapy to people with advanced pancreatic cancer. Our Centre for Drug Development is sponsoring and managing the trial, which is led by Professor Jeff Evans at the <a href="https://www.beatson.scot.nhs.uk/">Beatson West of Scotland Cancer Centre</a> in GlasgowÂ with other sites across the UK and in Europe to follow.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-events/cancer-research-uk-announces-dosing-first-patient-phase-2-trial-ginisortamab-therapy" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/lars_erwig_1.jpg" alt="lars erwig"></div><div class="content-panels-pane-body-copy"><h3>Beyond Borders: going global with clinical trials</h3>
<p>Our Director of Drug Development, Lars Erwig, talks about the need for global collaboration in clinical trials and international partnerships to pool expertise, resources and patients.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news-features/our-blog/going-global-clinical-trials">Discover more</a></div>
<p>Â </p>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/norwegian-cancer-society-ncs-logo-vector_0.png" alt="NCS logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and the Norwegian Cancer Society partner to bring more novel treatments into the clinic</h3>
<p>Cancer Research UK and <a href="https://kreftforeningen.no/en/">Norwegian Cancer Society</a>, two leading cancer research charities, announce a new multi-project strategic partnership to maximise our unique drug development capabilities to benefit people affected by cancer. Under this international partnership NCS will share funding and expertise to accelerate development of new cancer treatments into early phase trials with our Centre for Drug Development.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-and-norwegian-cancer-society-enter-partnership-broaden-early-phase-trial" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/thul-20cfe8ec-4814-4185-bef7f3737d09889a_1.jpg" alt="iv treatment"></div><div class="content-panels-pane-body-copy"><h3>First patient dosed in CDD Phase I trial ofÂ Aleta Biotherapeutics'Â CAR T cell engager</h3>
<p><a href="https://clinicaltrials.gov/study/NCT06045910">Our trial ofÂ first in class drug ALETA001</a>Â has treated the first patient. The trial is treating people with B-cell lymphoma whose disease has progressed after receiving CD19 CAR T cell therapy, offering a new therapy forÂ people with limited treatment options. The trial is managed, run and sponsored by CDD and led by Dr Sridhar Chaganti at <a href="https://www.uhb.nhs.uk/">University HospitalÂ Birmingham</a>.Â The trial is also treating people in Cambridge, Manchester, Leeds and London.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/aleta-biotherapeutics-and-cancer-research-uks-centre-drug-development-announce-first-patient" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/app_test_op_520_0.png" alt="patient on laptop"></div><div class="content-panels-pane-body-copy"><h3>More of our patients to have access to Trialmap to improve their experience of our clinical trials</h3>
<p>Two more of our trials, due to open in 2024, will give each patient the opportunity to manage their own trial journey with theÂ <a href="https://www.stitchhealth.co/">Stitch</a>Â Trialmap app. The specially tailored app means that people on these trials will be able to view information about the trial, get reminders about appointments, contact CRUK's nurses for support and feedback their experiences so we can hear directly from patients throughout the trial.</p>
<div class="more"><a href="https://www.stitchhealth.co/news/cancer-research-uk-partnership-new-studies" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/gavin_image.jpg" alt="Gavin Halbert"></div><div class="content-panels-pane-body-copy"><h3>Director of our Formulation Unit awarded OBE</h3>
<p>CDD is very proud to announce that the work and research of Professor Gavin Halbert, the long time Director of our <a href="https://www.strath.ac.uk/research/subjects/pharmacybiomedicalsciences/cancerresearchukfomulationunit/">Formulation Unit based at the University of Strathclyde</a>, has been recognised in the New Years Honours with an OBE. The CRUK Formation Unit was set up in the 1980s to provide drug formulation and manufacture for CRUK's early clinical trials of new experimental cancer treatments. Over the years Gavin's team at the Unit has worked on drugs such as temozolomide (approved for brain cancer in 2001), abiraterone (approved for prostate cancer in 2011) and rucaparib (approved for ovarian cancer in 2018), ensuring these new treatments were safe to be given to people for the first time in CDD's clinical trials and smoothing their pathway towards approval for every day use in the clinic, ultimately benefiting many thousands of people worldwide.</p>
<div class="more"><a href="https://news.cancerresearchuk.org/2024/01/05/cancer-research-uk-celebrates-new-year-honours-2024/" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/cruk_cdd_cmyk_2023.jpg" alt="CDD logo"></div><div class="content-panels-pane-body-copy"><h3>CRUK appoints new Director of CDD</h3>
<p>CRUK appoints industry veteran Dr Lars Erwig as the new Director for our Centre for Drug Development, the world's only charity-funded drug development facility.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-appoints-new-director-lead-its-centre-drug-development" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/clinical_1.jpg" alt="coughing patient"></div><div class="content-panels-pane-body-copy"><h3>CDD reports the results of the SPIKE1 trial</h3>
<p>We report the results of our SPIKE1 clinical trial of camostat in people who tested positive for Covid-19.</p>
<div class="more"><a href="https://clinicaltrials.gov/study/NCT04455815" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/kwf-logo-rgb-1024x277_0.png" alt="KWF logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and KWF collaborate to advance novel treatments into the clinic</h3>
<p>Cancer Research UK and <a href="https://www.kwf.nl/">KWF Dutch Cancer Society</a>, two of the worlds largest charitable funders of cancer research, announce a new multi-project strategic partnership to advance promising therapeutic agents for cancer through early clinical development. This international collaboration gives us a global outlook on cancer, broadening the potential benefit to patients worldwide.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-and-kwf-dutch-cancer-society-enter-partnership-bring-multiple-drugs" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/esmo-2023-2_1.jpg" alt="ESMO23"></div><div class="content-panels-pane-body-copy"><h3>Progress from CDD's novel antibody trial</h3>
<p>Clinical data from our trial of Hummingbirdâs anti-HER3 antibodyÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-of-hmbd-001-for-solid-cancers-that-have-spread">HMBD001 for the treatment of people with HER3 driven cancer</a>Â led by Professor Johann de Bono at <a href="https://www.royalmarsden.nhs.uk/">the Royal Marsden NHS Foundation Trust</a>Â were presented at the European Society for Medical Oncology Congress in Madrid (ESMO 2023).</p>
<div class="more"><a href="https://hummingbirdbioscience.com/hummingbird-bioscience-announces-positive-phase-i-clinical-data-for-hmbd-001-monotherapy-trial-at-the-european-society-for-medical-oncology-congress-2023/" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/small_-_jpg-5649_3.jpg" alt="nurses pic"></div><div class="content-panels-pane-body-copy"><h3>People with rare cancers given hope by CDD's DETERMINE trial</h3>
<p>Read in The Observer about 2 patients on <a href="http://www.cruk.org/determine">DETERMINE</a>, our large multi-drug precision medicine trial, who have seen their tumours reduce following treatment.Â DETERMINE offers people with rare cancer drugs already approved for more common cancers to see if they also work in rare cancers.Â The trial is led by Dr Matt Krebs at the <a href="https://www.christie.nhs.uk/">Christie NHS Foundation Trust</a>, Dr Lynley Marshall at theÂ <a href="https://www.royalmarsden.nhs.uk/">Royal Marsden NHS Foundation Trust</a>Â and Professor Gary Middleton at <a href="https://www.birmingham.ac.uk/research/ecmc/index.aspx">Birmingham Experimental Cancer Medicine Centre</a>. DETERMINE is also treating people in Belfast, Glasgow,Â Edinburgh, Cardiff, Newcastle, Liverpool, Sheffield, Leicester, Bristol, Cambridge, Oxford, Southampton and London.</p>
<div class="more"><a href="https://www.theguardian.com/science/2023/oct/14/patients-with-rare-cancers-given-hope-by-uk-led-drug-match-trial" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/webimage-5c7aca7a-919e-4dc8-b9d7b12bc6520d25_0.jpg" alt="nurses pic"></div><div class="content-panels-pane-body-copy"><h3>First patient dosed in CDD trial of new cancer immunotherapy</h3>
<p>Cancer Research UK and <a href="https://soseiheptares.com/">Sosei Heptares</a>Â announceÂ the first patient has been dosed <a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-htl0039732-and-other-cancer-drugs-for-solid-tumours-that-have-spread">our trial of Sosei's cancer immunotherapy HTL0039732</a>, a novel EP4 antagonist.Â Our Centre for Drug Development is Sponsoring and managing the trial, which is <a href="https://crukcambridgecentre.org.uk/news/first-patient-recruited-cambridge-novel-cancer-immunotherapy-trial?">led by Dr Bristi Basu</a> at theÂ <a href="https://www.ecmcnetwork.org.uk/cambridge">Cambridge Experimental Cancer Medicine Centre</a>Â and Dr Debashis Sarker atÂ <a href="https://www.guysandstthomas.nhs.uk/">Guys and St Thomas' London</a>. The trial is also treating people at other ECMCs at in Manchester, Cardiff and Liverpool.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/sosei-heptares-and-cancer-research-uk-announce-dosing-first-patient-phase-1/2a-trial-cancer" target="_blank">Discover more</a></div>
<div class="more">Â </div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/nature_0.png" alt="Nature logo"></div><div class="content-panels-pane-body-copy"><h3>New class of antibody shows promise for cancer patients</h3>
<p>MOv18 IgE is a novel class of antibody developed by researchers at <a href="https://www.kcl.ac.uk/news/trial-shows-promise-for-new-antibody-cancer-treatment">King's College London</a>Â that targetsÂ the folate receptor alpha antigen. Our Centre for Drug Development funded and supported the preclinical development of MOv18 IgE, then funded, sponsored and conducted <a href="https://clinicaltrials.gov/study/NCT02546921">the first in class Phase I clinical trial</a>Â led by Professor James Spicer at King's College London. Read more about it in <a href="https://www.nature.com/articles/s41467-023-39679-9">Nature Communications</a>.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/new-class-antibody-drug-shows-promise-cancer-patients" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/southampton_cruk_research_nurses_8.jpg" alt="southampton nurses"></div><div class="content-panels-pane-body-copy"><h3>CDD and Lineage Cell Therapeutics report the results of cancer vaccine trial</h3>
<p>We report the results of ourÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-of-a-vaccine-called-ast-vac2-for-non-small-cell-lung-cancer">Phase 1 clinicalÂ trial of first in class drug VAC2</a>Â in people withÂ non-small cell lung cancer.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/topline-phase-1-study-results-vac2-treatment-advanced-non-small-cell-lung-cancer?" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/prime-rose.jpg" alt="prime rose logo"></div><div class="content-panels-pane-body-copy"><h3>CDD joins PRIME-ROSE to boost patient access to innovative treatments</h3>
<p>PRIME-ROSE, a Europe-wide trial networkÂ with 24 partners in 17 countries led byÂ <a href="https://www.ous-research.no/home/kt/Group+members/14789">Professor Kjetil TaskÃ©n</a>Â and theÂ <a href="https://www.uio.no/english/">University of Oslo</a>, aims to boost patient access toÂ <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precision-medicine">precision cancer medicine</a>Â (PCM) treatments. Our Centre for Drug Development joins as an associate partner in PRIME-ROSE to represent the UK as the lead organisation runningÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-of-targeted-treatment-for-rare-cancers-that-have-spread-determine">DETERMINE</a>,Â our PCM trial open to adult, young adult and paediatric patients with any rare cancer.Â Our collaborationÂ with European colleagues to harmonise trial designs and share data will help speed up assessment of these treatments to bring new life-prolonging treatment options to people with cancer.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-joins-european-precision-cancer-medicine-trial-consortium" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/clinical_trials_landing_hero_1.jpg" alt="nurses"></div><div class="content-panels-pane-body-copy"><h3>Results of CDD's first in class MOv18 IgE antibody trial</h3>
<p>See the results of our first in class clinical trial of IgE antibody MOv18.Â It is the worldâs first clinical trial of a new class of immunotherapy drugs which fight cancer using one of the bodyâs natural defences.</p>
<div class="more"><a href="https://beta.clinicaltrials.gov/study/NCT02546921" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/ucb_logo2_0.png" alt="UCB logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and UCB collaborate to advance novel antibodies into the clinic</h3>
<p>Cancer Research UK and <a href="https://www.ucb.com/">UCB</a>, a global biopharmaceutical company, announce a clinical development collaboration to advance two of UCB's antibody candidates through clinical trials: UCB6114, a potential first in class antibody targeting gremlin-1, and UCB4594, an antibody targeting HLA-G. The trials will be developed, sponsored and managed by our Centre for Drug Development.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-signs-multi-project-collaboration-ucb-advance-oncology-antibody-candidates" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/hummingbird_bioscience_logobigger_2.jpg" alt="hummingbird logo"></div><div class="content-panels-pane-body-copy"><h3>Hummingbird Bioscience exercise the option to licence CDD's clinical trialÂ results of HMBD001Â </h3>
<p>Cancer Research Horizons andÂ <a href="https://hummingbirdbioscience.com/">Hummingbird Bioscience</a>Â announceÂ that Hummingbird BioscienceÂ has exercised their option to licence theÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-of-hmbd-001-for-solid-cancers-that-have-spread">first in human clinical trial results of anti-HER3 antibody HMBD001</a>.Â Our Centre for Drug Development is sponsoring and managing the trial which is led by Professor Johann de Bono at the <a href="https://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/royal-marsden-sutton-surrey">Royal Marsden Hospital</a> andÂ <a href="https://www.icr.ac.uk/home">Institute of Cancer Research</a> with other sites in Oxford,Â NewcastleÂ and Manchester.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/hummingbird-bioscience-exercises-its-option-license-clinical-trial-results-cancer-research-uk" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/621f9140654abf384c30d640.png" alt="novartis logo"></div><div class="content-panels-pane-body-copy"><h3>Novartis joins CDD's DETERMINE trial for rare paediatric and adult cancers</h3>
<p>CDD welcomesÂ <a href="https://www.novartis.com/">Novartis</a>Â on board.Â <a href="http://www.cruk.org/determine">DETERMINE</a>,Â a large multi-drug, precision medicine platform trial for adults and children with any rare cancer type, was set up by CDD in collaboration withÂ <a href="https://www.manchester.ac.uk/">the University of Manchester</a>Â and Roche.Â Novartis is now joining as the second pharma partner to provide access to their targeted treatments for trial participants.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/novartis-joins-cancer-research-uk-trial-rare-cancers" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/large-21.04.22_1288.jpg" alt="patient with mobile"></div><div class="content-panels-pane-body-copy"><h3>First of its kind Trialmap app to help improve patients' experience of our clinical trials</h3>
<p>Our collaboration with <a href="https://www.stitchhealth.co/">Stitch</a>Â creates a unique opportunity for each patient to manage their own trial journey with an app so we can hear directly from patients throughout the trial. CDD has worked with ourÂ patient involvement networkÂ to create the specially tailored app Trialmap which is being piloted on one of our clinical trials. People on our trial will be able to view information about the trial, get reminders about appointments, contact CRUK's nurses for support and feedback their experiences. We will apply their insights to design more patient-centred clinical trials for the best possible experience for our patients.Â </p>
<div class="more"><a href="https://news.cancerresearchuk.org/2022/11/28/first-of-its-kind-app-for-patients-on-clinical-trials-being-piloted-by-cancer-research-uk/" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/determine_logo_lockup_aw_stacked_rgb_1.jpg" alt="determine logo"></div><div class="content-panels-pane-body-copy"><h3>DETERMINE trial opens to treat rare adult and children's cancers</h3>
<p>Cancer Research UK, <a href="https://www.manchester.ac.uk/">the University of Manchester</a> and <a href="https://www.roche.com/">Roche</a>Â openÂ <a href="http://www.cruk.org/determine">DETERMINE</a>, a large multi-drug, precision medicine trial for adults and children with rare cancers who need more treatment options.Â DETERMINE is sponsored and managed by our Centre for Drug Development and led by Dr Matt Krebs at the <a href="https://www.christie.nhs.uk/">Christie NHS Foundation Trust</a>. We aim to find out if treatments already approved for treating other cancer types will also work in rare cancers.Â Roche is providing 7 of their targeted drugs and other pharmaceutical partners are expected to join and contribute their drugs as the trial progresses.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/precision-medicine-trial-opens-rare-adult-and-paediatric-cancers" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/images.png" alt="Aleta logo"></div><div class="content-panels-pane-body-copy"><h3>Innovation Passport granted to ALETA001</h3>
<p>The <a href="https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency">MHRA</a> has granted an Innovation Passport for ALETA001,Â <a href="http://www.aletabio.com/">Aleta Biotherapeutics</a>' CAR T-cell engager, under theÂ <a href="https://www.gov.uk/guidance/innovative-licensing-and-access-pathway">Innovative Licensing and Access Pathway</a> (ILAP).Â ILAP aims to accelerate development of new medicines. ALETA001 has been developed to benefit people with B-cell lymphoma whose disease has progressed after receiving CD19 CAR T-cell therapy, aiming to offerÂ a new therapy forÂ people with limited treatment options. The first clinical trial of ALETA001 will be developed, managed and sponsored by our Centre for Drug Development and led by Dr Sridhar Chaganti at <a href="https://www.uhb.nhs.uk/">University HospitalÂ Birmingham</a>.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/aleta-biotherapeutics-receives-innovation-passport-designation-biologic-car-t-cell-therapy" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/sh_logo.png" alt="SH logo"></div><div class="content-panels-pane-body-copy"><h3>CDD and Sosei Heptares join forces to advance cancer immunotherapy into the clinic</h3>
<p>Cancer Research UK and <a href="https://soseiheptares.com/">Sosei Heptares</a>, an international biopharmaceutical company and world leader in GPCR-focussed structure-based drug design and development, announceÂ an agreement to bring Sosei's cancer immunotherapy HTL0039732, a novel selective EP4 antagonist, into the first clinical trial in people with cancer. HTL0039732 is proposed for a range of cancers including colorectal, gastro-oesophageal, prostate and head and neck cancer. The trial will be developed, sponsored and managed by our Centre for Drug Development.Â </p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-and-sosei-heptares-sign-agreement-advance-cancer-immunotherapy-candidate" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/cancer_research_horizons_1.jpg" alt="CR Horizons"></div><div class="content-panels-pane-body-copy"><h3>CDD working in collaboration with Cancer Research HorizonsÂ </h3>
<p>Cancer Research UK's new and ambitious approach to driving innovation in the development of new treatments for patients, combines the power of academia and industry. <a href="https://www.cancerresearchhorizons.com/">Cancer Research Horizons</a> brings under one umbrella CRUKâs established drug discovery laboratories, network of world-class biology, cutting-edge technology platforms and clinical expertise, offering a unique R&amp;D portfolio. Partners gain access to our extensive network of 4,000 world-leading cancer researchers and a discovery research portfolio investment of over Â£400 million annually.</p>
<div class="more"><a href="https://www.cancerresearchhorizons.com/news/cancer-research-uk-reveals-innovation-engine-underpinned-ps400m-portfolio-cutting-edge" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/nature.png" alt="Nature logo"></div><div class="content-panels-pane-body-copy"><h3>Anti-tumour immune effects seen in CDD's trial of AMG319 published</h3>
<p>Read in <a href="https://www.nature.com/">Nature</a> about the immunological effects seen in our <a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-amg-319-for-head-and-neck-cancer">Phase II trial of AMG319</a>, a PI3KÎ´ inhibitor. Intermittent PI3KÎ´ inhibition sustains anti-tumour immunity and reduces immune response adverse events. The CDD trial was led by <a href="https://www.liverpool.ac.uk/systems-molecular-and-integrative-biology/staff/christian-ottensmeier/">Professor Christian Ottensmeier</a> and conducted in collaboration with <a href="https://www.amgen.com/">Amgen</a>.</p>
<div class="more"><a href="https://www.nature.com/articles/s41586-022-04685-2" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/webimage-10892ecb-156a-4336-ab0ca42482fe4806.jpg" alt="nurses imperial"></div><div class="content-panels-pane-body-copy"><h3>Results of CDD's first in class MCT1 inhibitor trial</h3>
<p>See the results of our clinical trial of first in class MCT1 inhibitor AZD3965 in people with solid tumours and lymphoma.</p>
<div class="more"><a href="https://clinicaltrials.gov/ct2/show/study/NCT01791595" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/webimage-8ffffce4-f17c-4021-b56951d6349f573b_3.png" alt="nurses pic"></div><div class="content-panels-pane-body-copy"><h3>CDD's CURATE trial treats the first patient</h3>
<p>Cancer Research UK and the <a href="https://teontherapeutics.com/">Teon Therapeutics</a> announce the first patientÂ has been treated in theÂ <a href="/about-cancer/find-a-clinical-trial/a-trial-of-tt-702-for-solid-tumours-that-have-spread-curate">CURATE trial</a>Â of Teonâs first in class A2BR-specific antagonist, TT702, for people with a range of difficult to treat cancers. The trial is run and sponsored by our Centre for Drug Development and led by Professor Johann de Bono at <a href="https://www.royalmarsden.nhs.uk/">the Royal Marsden NHS Foundation Trust</a>Â with other sites in Manchester and Southampton.</p>
<div class="more"><a href="http://commercial.cancerresearchuk.org/cancer-research-uk-and-teon-therapeutics-announce-first-patient-dosed-clinical-trial-hard-treat" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/large-cruk_bdu51987_hero_2.jpg" alt="BDU staff"></div><div class="content-panels-pane-body-copy"><h3>Clinical development of MOv18 IgE continues</h3>
<p>Our Centre for Drug Development funded and supported the preclinical development of MOv18 IgE, then sponsored and conducted <a href="/about-cancer/find-a-clinical-trial/a-trial-looking-at-mov18-ige-for-advanced-solid-tumours">the first in class Phase I clinical trial</a>Â led by Professor James Spicer at King's College London. MOv18 IgE is a novel class of antibody that targetsÂ the folate receptor alpha antigen. King's immuno-oncology spin-out Epsilogen has now raised funds from Novartis and other investor partners to enable continued development of the antibody to treat ovarian cancer. Read more about it fromÂ <a href="https://www.guysandstthomasbrc.nihr.ac.uk/2022/03/02/cancer-immunotherapy-spin-out-gains-30m-funding/">Guy's and St Thomas' Biomedical Research Centre</a>, <a href="https://www.kcl.ac.uk/news/kings-immuno-oncology-spin-out-gains-30m-funding">King's College London</a>, andÂ <a href="https://www.fiercebiotech.com/biotech/novartis-backs-epsilogens-bid-turn-cinderella-antibody-new-class-cancer-drug">Fiercebiotech</a>.Â </p>
<div class="more"><a href="https://epsilogen.com/epsilogen-completion-30million-series-b-financing/" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/webimage-972e4dd2-2e7d-4950-b985-ccd33775d759.jpg" alt="CRUK 20yrs"></div><div class="content-panels-pane-body-copy"><h3>Celebrating life-saving research</h3>
<p>On World Cancer Day our Centre for Drug Development delivered a fascinating webinar giving Cancer Research UK supporters a closer look at our life-saving research.</p>
<div class="more"><a href="https://sway.office.com/1VMpcUxlPFSEeGfY?ref=Link&amp;loc=play" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/large-12627_hero_0.jpg" alt="patients hands"></div><div class="content-panels-pane-body-copy"><h3>CDD's tailored patient involvement in clinical trials</h3>
<p>Read on Applied Clinical Trials about how the team at our Centre for Drug Development makes sure people affected by cancer are at the heart of our work, helping us develop trials and medicines that are better tailored to patientsâ needs.</p>
<div class="more"><a href="https://www.appliedclinicaltrialsonline.com/view/tailored-patient-involvement-in-clinical-trials" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/thul-810b2ee7-176e-44f8-b3b7966f6bfb4509_0.png" alt="iv treatment"></div><div class="content-panels-pane-body-copy"><h3>First patient dosed in hard to treat cancers</h3>
<p>Cancer Research UKÂ andÂ <a href="https://hummingbirdbioscience.com/">Hummingbird Bioscience</a>Â announce the first patient has been treated in our <a href="/about-cancer/find-a-clinical-trial/a-trial-of-hmbd-001-for-solid-cancers-that-have-spread">first in human trial of Hummingbird's anti-HER3 antibody HMBD001</a>. The trial aims to treat people with advanced HER3-positive solid tumours, including colorectal, head and neck, melanoma, breast, gastric, ovarian, prostate, and bladder cancers. Our Centre for Drug Development is sponsoring and managing the trial, which is led by Professor Johann de Bono at the <a href="https://www.icr.ac.uk/home">Institute of Cancer Research</a> with other sites in Oxford,Â Newcastle and Manchester.</p>
<div class="more"><a href="http://commercial.cancerresearchuk.org/cancer-research-uk-announces-first-patient-dosed-trial-hard-treat-cancers" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/cruk_logo_5.jpg" alt="CRUK logo"></div><div class="content-panels-pane-body-copy"><h3>Why does Cancer Research UK foster partnershipsÂ betweenÂ industry and academia?</h3>
<p>Read our article in <a href="https://www.nature.com/nrc/">Nature Reviews Cancer</a>Â about how research funders like CRUKÂ are uniquely placed to develop and promote collaborations between multiple partners, including industry, in a positive and ethical way.</p>
<div class="more"><a href="https://rdcu.be/cc14S" target="_blank">Discover more</a></div>
</div></div><div class="content-panel-separator"></div><div class="content-panels-pane-body"><div class="content-panels-pane-image"><img src="/sites/default/files/gosh_logo.png" alt="GOSH logo"></div><div class="content-panels-pane-body-copy"><h3>Results of CDD's CAR T cell trial in neuroblastoma are published</h3>
<p>We report <a href="https://clinicaltrials.gov/ct2/show/NCT02761915">results from our trial</a>Â at <a href="https://www.gosh.nhs.uk/">Great Ormond Street Hospital</a>Â in collaboration with UCL andÂ <a href="https://www.autolus.com/">Autolus Therapeutics plc</a>. These resultsÂ areÂ the first early evidence that GD2 CAR T cells show activityÂ in solid tumours without causing neurotoxicity.</p>
<div class="more"><a href="https://www.science.org/doi/10.1126/scitranslmed.abd6169" target="_blank">Discover more</a></div>
</div></div>  </div>

  
  </div>
              </div>
        
        
        
        
      <div id="panel-22" class="col-md-12 col-sm-12 col-xs-12">
              </div>

                      <div id="panel-23" class="col-md-12 col-sm-12 col-xs-12">
                  
<div>
  
      
  
  <div class="fieldable-panels-pane">
    

<div class="field field-type-text-with-summary">
  
  
                <div class="field-item"><style>
.horizontal-nav--desktop ul {
    padding: 0;
    margin: 0;
    border-top: none;
    border: 1px solid #e3e3e3;
    -moz-border-radius: 3px;
    -webkit-border-radius: 3px;
    border-radius: 3px;
}
</style></div>
        </div>
</div>

  </div>
              </div>
        

</div>
  
            <div id="mobile-nav"></div>
     <!-- end of main content -->
    </main>

    
    
  </div><!-- #wrapper -->
</div>

<footer role="contentinfo">
  <div class="container">
    <div class="footer-links">
      <div class="footer-links__list">
        <h2>Speak to a nurse</h2>
        <ul>
          <li><a href="tel://0808%20800%204040">Nurse Helpline<br>0808 800 4040</a></li>
          <li>Questions about cancer? Call freephone<br>9 to 5 Monday to Friday or <a href="/about-us/contact-us/talk-to-our-nurses?secure=true">email us</a></li>
        </ul>
      </div>

      <div class="footer-links__list">
        <h2>Quick links</h2><ul class="links"><li class="0 first"><a href="/get-involved/find-a-shop">Find local shops</a></li>
<li class="1"><a href="https://shop.cancerresearchuk.org/?utm_source=cruk_footer">Shop online</a></li>
<li class="2"><a href="/about-us/contact-us">Contact us</a></li>
<li class="3 last"><a href="/about-us/charity-jobs">Jobs</a></li>
</ul>      </div>

      <div class="footer-links__icons">
        <h2>Follow us</h2>
        <ul>
          <li>
            <a href="https://www.facebook.com/cancerresearchuk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/facebook_icon.svg" width="40" height="40" alt="Like Cancer Research UK on Facebook">
            </a>
          </li>
          <li>
            <a href="https://twitter.com/CR_UK">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/twitter_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Twitter">
            </a>
          </li>
          <li>
            <a href="https://www.instagram.com/cr_uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/instagram_icon.svg" width="40" height="40" alt="Follow Cancer Research UK on Instagram">
            </a>
          </li>
          <li>
            <a href="https://www.linkedin.com/company/cancer-research-uk/">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/linkedin_icon.svg" width="40" height="40" alt="Connect with Cancer Research UK on LinkedIn">
            </a>
          </li>
          <li>
            <a href="https://www.youtube.com/user/cancerresearchuk">
              <img src="/sites/all/themes/custom/cruk/images/social_icons/youtube_icon.svg" width="40" height="40" alt="Subscribe to Cancer Research UK on YouTube">
            </a>
          </li>
        </ul>
      </div>
    </div>

    <div class="footer-links">
      <div class="footer-links__list--horizontal">
        <ul class="links"><li class="0 first"><a href="/about-cancer/about-our-information">About our information</a></li>
<li class="1"><a href="/about-us/utilities/terms-and-conditions">Terms and conditions</a></li>
<li class="2"><a href="/about-us/utilities/privacy-statement">Privacy</a></li>
<li class="3"><a href="/modern-slavery-transparency-statement">Modern Slavery Statement</a></li>
<li class="4"><a href="/about-us/utilities/cookies-policy">Cookies</a></li>
<li class="5"><a href="/about-us/utilities/accessibility">Accessibility</a></li>
<li class="6 last"><a href="/sitemap">Sitemap</a></li>
</ul>      </div>
    </div>

    <div id="awards" class="footer-secondary-content">
      <a href="https://www.fundraisingregulator.org.uk/"><img src="/sites/all/themes/custom/cruk/images/fund-reg.svg" alt="Registered with Fundraising Regulator (logo)" width="165" height="52"></a>
    </div>

    <address class="footer-secondary-content">Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ.</address>
  </div>
</footer>
<script src="https://www.cancerresearchuk.org/sites/all/libraries/modernizr/modernizr-3.3.1.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery/2.1/jquery.min.js?v=2.1.4"></script>
<script>jQuery.migrateMute=true;jQuery.migrateTrace=false;</script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/jquery-migrate/1/jquery-migrate.min.js?v=1"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-extend-3.4.0.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery-html-prefilter-3.5.0-backport.js?v=2.1.4"></script>
<script src="https://www.cancerresearchuk.org/misc/jquery.once.js?v=1.2"></script>
<script src="https://www.cancerresearchuk.org/misc/drupal.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.core.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.widget.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/external/jquery.cookie.js?v=67fb34f6a866c40d0570"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/replace/ui/ui/minified/jquery.ui.position.min.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ui/jquery.ui.position-1.13.0-backport.js?v=1.10.2"></script>
<script src="https://www.cancerresearchuk.org/misc/ajax.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/jquery_update/js/jquery_update.js?v=0.0.1"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/clientside_validation_rule_pword_match/js/clientside_validation_rule_pword_match.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/js/cruk_donate.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/jquery.kinetic.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_gc_timeline/js/timeline.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/entityreference/js/entityreference.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/geofield_gmap/geofield_gmap.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/resp_img/resp_img.js?" class="optanon-category-fun cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_config_fieldable_panels/js/cruk_config_fieldable_panels_geolocation.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/cruk_core_info.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_core_info/js/clipboard.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_shine_night_walks/js/select-styling.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_donate/selectmenu/jquery.ui.selectmenu.js?v=1.3.0"></script>
<script src="https://www.cancerresearchuk.org/misc/progress.js?v=7.103"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustPlaceholder.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustDynatrace.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_onetrust/js/crukOneTrustRefreshBlockedScripts.js?"></script>
<script src="https://platform.twitter.com/widgets.js" class="optanon-category-tar cruk-onetrust-blocked-scripts"></script>
<script src="https://www.cancerresearchuk.org/sites/all/modules/contrib/extlink/js/extlink.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/collapse.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/dropdown.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/transition.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/bootstrap/bootstrap/carousel.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/packery.pkgd.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/slick.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/pure.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/jquery.mobile.custom.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/media.match.min.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/enquire.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/vendor/ios-orientationchange-fix.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/console.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/tabs_to_accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/cruk-accordion.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.megamenu.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/script.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/jquery.mobile-rebrand.js?"></script>
<script src="https://www.cancerresearchuk.org/sites/all/themes/custom/cruk/scripts/interactive_timeline.js?"></script>
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","setHasJsCookie":0,"ajaxPageState":{"theme":"cruk","theme_token":"OW-UPhYlFB_V9_3MADY_FkFN2cgFY-HEqbrGSi2BcRQ","jquery_version":"2.1","js":{"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/cruk_image_gallery.js":1,"0":1,"sites\/all\/libraries\/modernizr\/modernizr-3.3.1.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/2.1\/jquery.min.js":1,"1":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery-migrate\/1\/jquery-migrate.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery-html-prefilter-3.5.0-backport.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"misc\/ui\/jquery.ui.position-1.13.0-backport.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/clientside_validation_rule_pword_match\/js\/clientside_validation_rule_pword_match.js":1,"sites\/all\/modules\/custom\/cruk_donate\/js\/cruk_donate.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/jquery.kinetic.min.js":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/js\/timeline.js":1,"sites\/all\/modules\/contrib\/entityreference\/js\/entityreference.js":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.js":1,"sites\/all\/modules\/contrib\/resp_img\/resp_img.js":1,"sites\/all\/modules\/custom\/cruk_config_fieldable_panels\/js\/cruk_config_fieldable_panels_geolocation.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/cruk_core_info.js":1,"sites\/all\/modules\/custom\/cruk_core_info\/js\/clipboard.min.js":1,"sites\/all\/modules\/custom\/cruk_image_gallery\/js\/slick.min.js":1,"sites\/all\/modules\/custom\/cruk_shine_night_walks\/js\/select-styling.js":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.js":1,"misc\/progress.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustPlaceholder.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustDynatrace.js":1,"sites\/all\/modules\/custom\/cruk_onetrust\/js\/crukOneTrustRefreshBlockedScripts.js":1,"https:\/\/platform.twitter.com\/widgets.js":1,"sites\/all\/modules\/contrib\/extlink\/js\/extlink.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/collapse.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/dropdown.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/transition.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/bootstrap\/bootstrap\/carousel.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/packery.pkgd.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/slick.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/pure.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/jquery.mobile.custom.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/media.match.min.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/enquire.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/vendor\/ios-orientationchange-fix.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/console.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/tabs_to_accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/cruk-accordion.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.megamenu.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/script.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/jquery.mobile-rebrand.js":1,"sites\/all\/themes\/custom\/cruk\/scripts\/interactive_timeline.js":1},"css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"0":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"modules\/aggregator\/aggregator.css":1,"sites\/all\/modules\/custom\/cruk_gc_timeline\/css\/grand_challenge_timeline.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/geofield_gmap\/geofield_gmap.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/css\/extlink.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/all\/themes\/custom\/cruk\/layouts\/100_333_73_landing_wide_multi_panels\/100_333_73_landing_wide_multi_panels.css":1,"sites\/all\/modules\/custom\/cruk_donate\/selectmenu\/jquery.ui.selectmenu.css":1,"sites\/all\/modules\/contrib\/node_embed\/plugins\/node_embed\/node_embed.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/reset-html5.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership-default.css":1,"sites\/all\/themes\/contrib\/mothership\/mothership\/css\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/css\/tabs_to_accordion.css":1,"sites\/all\/themes\/custom\/cruk\/css\/style.css":1,"sites\/all\/themes\/custom\/cruk\/css\/cruk.menus.css":1,"sites\/all\/themes\/custom\/cruk\/css\/mobile.menu.css":1,"sites\/all\/themes\/custom\/cruk\/css\/slick.css":1,"sites\/all\/themes\/custom\/cruk\/css\/content_panel.css":1,"sites\/all\/themes\/custom\/cruk\/css\/scroller.css":1,"sites\/all\/themes\/custom\/cruk\/normalize.css":1,"sites\/all\/themes\/custom\/cruk\/reset.css":1,"sites\/all\/themes\/custom\/cruk\/reset-html5.css":1,"sites\/all\/themes\/custom\/cruk\/mothership.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-default.css":1,"sites\/all\/themes\/custom\/cruk\/mothership-devel-mediaqueries.css":1,"sites\/all\/themes\/custom\/cruk\/css\/print.css":1,"public:\/\/css_injector\/css_injector_31.css":1,"public:\/\/css_injector\/css_injector_131.css":1,"public:\/\/css_injector\/css_injector_156.css":1,"public:\/\/css_injector\/css_injector_196.css":1,"public:\/\/css_injector\/css_injector_201.css":1,"public:\/\/css_injector\/css_injector_206.css":1,"public:\/\/css_injector\/css_injector_211.css":1,"public:\/\/css_injector\/css_injector_226.css":1,"public:\/\/css_injector\/css_injector_241.css":1,"public:\/\/css_injector\/css_injector_251.css":1,"public:\/\/css_injector\/css_injector_261.css":1,"public:\/\/css_injector\/css_injector_276.css":1,"public:\/\/css_injector\/css_injector_281.css":1,"public:\/\/css_injector\/css_injector_291.css":1,"public:\/\/css_injector\/css_injector_296.css":1,"public:\/\/css_injector\/css_injector_306.css":1,"public:\/\/css_injector\/css_injector_361.css":1,"public:\/\/css_injector\/css_injector_371.css":1,"public:\/\/css_injector\/css_injector_376.css":1,"public:\/\/css_injector\/css_injector_426.css":1,"public:\/\/css_injector\/css_injector_441.css":1,"public:\/\/css_injector\/css_injector_466.css":1,"public:\/\/css_injector\/css_injector_471.css":1,"public:\/\/css_injector\/css_injector_516.css":1,"public:\/\/css_injector\/css_injector_561.css":1,"public:\/\/css_injector\/css_injector_576.css":1,"public:\/\/css_injector\/css_injector_581.css":1,"public:\/\/css_injector\/css_injector_610.css":1,"public:\/\/css_injector\/css_injector_616.css":1,"public:\/\/css_injector\/css_injector_617.css":1,"public:\/\/css_injector\/css_injector_619.css":1,"public:\/\/css_injector\/css_injector_620.css":1}},"respImg":{"default_suffix":"_breakpoint_one","current_suffix":false,"forceRedirect":"0","forceResize":"1","reloadOnResize":"0","useDevicePixelRatio":1,"suffixes":{"_breakpoint_two":640,"_breakpoint_three":480,"_breakpoint_four":320,"_breakpoint_one":1}},"extlink":{"extTarget":"_blank","extClass":"external","extLabel":"(link is external)","extImgClass":0,"extIconPlacement":0,"extSubdomains":1,"extExclude":"(twitter\\.com|facebook\\.com|addthis\\.com|cancerresearchuk\\.org|cruk\\.org|cruk01)","extInclude":"https:\/\/www.cancerresearchuk.org\/(sites\/default\/files\/*)","extCssExclude":".social-link,.ignore-external,.navbar,.cruk-nav,.footer-social,.about-cancer-footer-icons,.pane-node-field-landing-key-message","extCssExplicit":"","extAlert":0,"extAlertText":"This link will take you to an external web site.","mailtoClass":0,"mailtoLabel":"(link sends e-mail)","extUseFontAwesome":0}});</script>

      
<script src="https://www.cancerresearchuk.org/sites/all/modules/custom/cruk_image_gallery/js/cruk_image_gallery.js?"></script>
<script>
  function OptanonWrapper() {

    crukOneTrustUpdatePlaceholders();

    crukOneTrustUpdateDynatrace();

    crukOneTrustRefreshBlockedScripts();
}</script>
</body>
</html>
